Your session is about to expire
← Back to Search
Radiation Therapy
VMAT for Brain Tumor
N/A
Waitlist Available
Led By Alan M Nichol, MD
Research Sponsored by British Columbia Cancer Agency
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a new radiation technique called VMAT for patients with brain cancer that has spread. VMAT can treat the whole brain and give extra radiation to cancer spots at the same time. The goal is to see how well it works and what side effects it might have.
Eligible Conditions
- Metastatic Brain Tumors
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Whole brain radiotherapyExperimental Treatment1 Intervention
whole brain radiotherapy (WBRT) and a simultaneous integrated boost (SIB) using volumetric modulated arc therapy
Find a Location
Who is running the clinical trial?
British Columbia Cancer AgencyLead Sponsor
174 Previous Clinical Trials
94,184 Total Patients Enrolled
Alan M Nichol, MDPrincipal InvestigatorBritish Columbia Cancer Agency
1 Previous Clinical Trials
1,514 Total Patients Enrolled
Media Library
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger